籍强,吕骏卿,赵鑫,荣伟强.晚期NSCLC组织巨噬细胞表面Tim-3表达与临床特征和预后的关系.[J].中南医学科学杂志.,2021,(6):668-671, 702.
晚期NSCLC组织巨噬细胞表面Tim-3表达与临床特征和预后的关系
Correlation between Tim-3 on the surface of TAM and pathological features and prognosis in advanced NSCLC patients
投稿时间:2021-03-17  修订日期:2021-09-30
DOI:10.15972/j.cnki.43-1509/r.2021.06.012
中文关键词:  晚期非小细胞肺癌  肿瘤相关巨噬细胞  Tim-3  Gal-9
英文关键词:advanced non-small cell lung cancer  tumor-associated macrophage  Tim-3  Gal-9
基金项目:河北省2021年度医学科学研究课题计划(20210266) 作者简介:籍强,住院医师,研究方向为胸心血管外科疾病的诊治,E-mail为nuonuo44566@163.com。
作者单位
籍强 胸心血管外科,河北省张家口市075000 
吕骏卿 河北北方学院附属第一医院急诊科,河北省张家口市075000 
赵鑫 河北北方学院附属第一医院放疗科,河北省张家口市075000 
荣伟强 河北北方学院附属第一医院输血科, 河北省张家口市075000 
摘要点击次数: 309
全文下载次数: 218
中文摘要:
      目的探讨晚期非小细胞肺癌(NSCLC)患者肿瘤组织浸润巨噬细胞表面T细胞免疫球蛋白黏蛋白-3(Tim-3)表达特点,以及与其配体半乳凝素-9(Gal-9)组织表达、患者临床特征、预后的关系。 方法选择80例晚期NSCLC组织和30例肺良性病变肺组织,采用免疫组织化学法和流式细胞术分别检测组织Tim-3和Gal-9蛋白表达量,以及肿瘤相关巨噬细胞(TAM)表面Tim-3表达,并分析HLA-DR+TAM和CD163+TAM表面Tim-3表达与组织Tim-3表达、Gal-9表达、临床特征、总生存期的关系。 结果NSCLC组织Tim-3和Gal-9蛋白阳性表达率高于肺良性病变肺组织(P<0.05),且Tim-3在CD163+TAM阳性表达率高于HLA-DR+TAM(P<0.05)。NSCLC组织Gal-9蛋白表达与组织Tim-3蛋白表达呈正相关性(P<0.05)。HLA-DR+TAM表面和CD163+TAM表面Tim-3表达与患者肺外转移、TNM分期和2年生存预后有关(P<0.05)。HLA-DR+TAM表面Tim-3蛋白高表达亚组患者总生存期长于低表达亚组(P=0.003),而CD163+TAM表面Tim-3蛋白高表达亚组患者总生存期则短于低表达亚组(P=0.001)。 结论晚期NSCLC组织中Tim-3和Gal-3均呈高表达,Tim-3/Gal-3信号通路在NSCLC肺外转移、疾病发展及预后不良中的作用可能与TAM向M2型巨噬细胞极化导致的肺癌炎症微环境有关。
英文摘要:
      To detect the expressions of T cell immunoglobulin domain and mucin domain (Tim-3) on the surface of tumor-associated macrophages (TAM) and its correlation with galectin-9 (Gal-9) expression, pathological features and prognosis in patients with advancedadvanced non-small cell lung cancer(NSCLC). MethodsTissue samples from 80 advanced NSCLC patients and 30 patients with pulmonary benign diseases were collected into this study. Tim-3 and Gal-9 expressions in the tissues were detected by IHC and Tim-3 expressions on the surface of HLA-DR+ TAM or CD163+ TAM were detected by FCM. And their relationships with pathological features and death prognosis were analyzed. ResultsThe positive rates of Tim-3 and Gal-9 proteins in NSCLC tissues were higher than those in pulmonary benign disease tissues (P<0.05), while Tim-3 expression on the surface of CD163+TAM was higher than that on HLA-DR+TAM (P<0.05). Gal-9 expressions in NSCLC tissues were positively related with Tim-3protein expression in NSCLC tissues (P<0.05). Besides, Tim-3 expressions on the surface of CD163+TAM or HLA-DR+TAM would be related with TNM stage, extrapulmonary metastasis and 2y-survival prognosis (P<0.05). The median overall survival of patients with higher Tim-3 expression on HLA-DR+TAM was longer than that of patients with higher Tim-3 expression (P=0.003); and the median overall survival of patients with higher Tim-3 expression on CD163+TAM was shorter than that of patients with lower Tim-3 expression (P=0.001). ConclusionsIn advanced NSCLC patients, Tim-3 and Gal-9 proteins levels in NSCLC tissues would increase, and be related with TNM stage, extrapulmonary metastasis and poor prognosis. The possible mechanism may be the inflammatory effect of Tim-3/Gal-9 pathway for the M2 polarization of TAM in the tumor micro-enviroment.
查看全文  查看/发表评论  下载PDF阅读器
关闭
function PdfOpen(url){ var win="toolbar=no,location=no,directories=no,status=yes,menubar=yes,scrollbars=yes,resizable=yes"; window.open(url,"",win); } function openWin(url,w,h){ var win="toolbar=no,location=no,directories=no,status=no,menubar=no,scrollbars=yes,resizable=no,width=" + w + ",height=" + h; controlWindow=window.open(url,"",win); } &et=D67FB0004990587200991ABFA839915F1881B03D6E0131F27BA378783780F09ADD2B209A0CAEF8485715763600313015CFE25A83F6DFE639DDD7CC75F2D18CEE6FAEAE8954970A81C44DDE8A1BDD5165C811F6587AA833DE1DAFD26A12F17447EFB3BC07185BC8963EFC80E88A5D9B76E26C667B81CF92EE&pcid=A9DB1C13C87CE289EA38239A9433C9DC&cid=BB33F1C95224820A&jid=6A20DF2A798996E24F064D5ECF83A153&yid=9475FABC7A03F4AB&aid=81AC244D6BE664FB20DF391A8D487465&vid=&iid=B31275AF3241DB2D&sid=C6FC2A9EA7E6C4B9&eid=7CE01C3B379C2BD32F75862122E7E4D7&fileno=20210612&flag=1&is_more=0">